Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
F105470-5g | 5g | In stock | $15.90 | |
F105470-10g | 10g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $27.90 | |
F105470-25g | 25g | In stock | $45.90 | |
F105470-100g | 100g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $164.90 | |
F105470-500g | 500g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $738.90 |
Synonyms | Fmoc-Ile-OH|Fmoc-L-isoleucine|71989-23-6|N-Fmoc-L-isoleucine|N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-isoleucine|N-(9-Fluorenylmethoxycarbonyl)-L-isoleucine|MFCD00037125|(2S,3S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methylpentanoic acid|(2S,3S)-2- |
---|---|
Specifications & Purity | ≥99% |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Product Description | application: N-Fmoc-L-isoleucine is an unnatural amino acid used for peptidomimetics. It is also used as a pharmaceutical intermediate |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (2S,3S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylpentanoic acid |
---|---|
INCHI | InChI=1S/C21H23NO4/c1-3-13(2)19(20(23)24)22-21(25)26-12-18-16-10-6-4-8-14(16)15-9-5-7-11-17(15)18/h4-11,13,18-19H,3,12H2,1-2H3,(H,22,25)(H,23,24)/t13-,19-/m0/s1 |
InChi Key | QXVFEIPAZSXRGM-DJJJIMSYSA-N |
Canonical SMILES | CCC(C)C(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13 |
Isomeric SMILES | CC[C@H](C)[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13 |
WGK Germany | 3 |
PubChem CID | 2724629 |
Molecular Weight | 353.41 |
Beilstein | 4716717 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
A1917035 | Certificate of Analysis | Nov 15, 2022 | F105470 |
C2415108 | Certificate of Analysis | Sep 30, 2021 | F105470 |
D2301013 | Certificate of Analysis | Sep 30, 2021 | F105470 |
D2301014 | Certificate of Analysis | Sep 30, 2021 | F105470 |
H2325072 | Certificate of Analysis | Sep 30, 2021 | F105470 |
Solubility | Soluble in methanol (very faint turbidity). |
---|---|
Specific Rotation[α] | -12±1°, c = 1% in DMF |
Melt Point(°C) | 144-149°C |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H302:Harmful if swallowed H312:Harmful in contact with skin H332:Harmful if inhaled |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P301+P317:IF SWALLOWED: Get medical help. P317:Get emergency medical help. |
WGK Germany | 3 |
1. Chiao-Ting Yen,Tsong-Long Hwang,Yang-Chang Wu,Pei-Wen Hsieh. (2008-12-27) Design and synthesis of new N-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides as anti-inflammatory agents.. European journal of medicinal chemistry, 44 ((5)): (1933-1940). [PMID:19110343] |
2. K R Sunil Kumar,Takashi Kamei,Tuyoshi Fukaminato,Nobuyuki Tamaoki. (2014-04-01) Complete ON/OFF photoswitching of the motility of a nanobiomolecular machine.. ACS nano, 8 ((5)): (4157-4165). [PMID:24680285] |
3. Moise Ndao,Gil Goobes,Prashant S Emani,Gary P Drobny. (2016-04-05) A REDOR ssNMR Investigation of the Role of an N-Terminus Lysine in R5 Silica Recognition.. Langmuir : the ACS journal of surfaces and colloids, 34 ((29)): (8678-8684). [PMID:27039990] |
4. Stefan Eissler,Markus Kley,Dirk Bächle,Günther Loidl,Thomas Meier,Daniel Samson. (2017-06-22) Substitution determination of Fmoc-substituted resins at different wavelengths.. Journal of peptide science : an official publication of the European Peptide Society, 23 ((10)): (757-762). [PMID:28635051] |
5. Zdenek Kukacka,Marius Iurascu,Loredana Lupu,Hendrik Rusche,Mary Murphy,Lorenzo Altamore,Fabio Borri,Stefan Maeser,Anna Maria Papini,Julia Hennermann,Michael Przybylski. (2018-02-24) Antibody Epitope of Human α-Galactosidase\u2005A Revealed by Affinity Mass Spectrometry: A Basis for Reversing Immunoreactivity in Enzyme Replacement Therapy of Fabry Disease.. ChemMedChem, 13 ((9)): (909-915). [PMID:29473701] |
6. R Ashton Lavoie,Alice di Fazio,R Kevin Blackburn,Michael B Goshe,Ruben G Carbonell,Stefano Menegatti. (2019-04-11) Targeted Capture of Chinese Hamster Ovary Host Cell Proteins: Peptide Ligand Discovery.. International journal of molecular sciences, 20 ((7)): [PMID:30965558] |
7. Karthik Nadendla,Bhagyesh R Sarode,Simon H Friedman. (2019-05-24) Hydrophobic Tags for Highly Efficient Light-Activated Protein Release.. Molecular pharmaceutics, 16 ((7)): (2922-2928). [PMID:31117739] |
8. Yu-I Hsu,Tetsuji Yamaoka. (2019-08-21) Improved exposure of bioactive peptides to the outermost surface of the polylactic acid nanofiber scaffold.. Journal of biomedical materials research. Part B, Applied biomaterials, 108 ((4)): (1274-1280). [PMID:31429188] |
9. R Ashton Lavoie,Alice di Fazio,Taufika Islam Williams,Ruben Carbonell,Stefano Menegatti. (2019-10-28) Targeted capture of Chinese hamster ovary host cell proteins: Peptide ligand binding by proteomic analysis.. Biotechnology and bioengineering, 117 ((2)): (438-452). [PMID:31654407] |
10. Michał Padjasek,Maciej Maciejczyk,Michał Nowakowski,Olga Kerber,Maciej Pyrka,Wiktor Koźmiński,Artur Krężel. (2019-12-18) Metal Exchange in the Interprotein ZnII -Binding Site of the Rad50 Hook Domain: Structural Insights into CdII -Induced DNA-Repair Inhibition.. Chemistry (Weinheim an der Bergstrasse, Germany), 26 ((15)): (3297-3313). [PMID:31846102] |